Basic Information
LncRNA/CircRNA Name | AL163952.1 |
Synonyms | NA |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | tongue squamous cell carcinoma |
ICD-0-3 | C02 |
Methods | RNA-seq |
Sample | TSCC tissues |
Expression Pattern | differential expression |
Function Description | we identified ten lncRNAs (PART1, LINC00261,AL163952.1, C2orf48, FAM87A, LINC00052, LINC00472, STEAP3-AS1, TSPEAR-AS1 and ERVH48-1) as novel, potential prognostic biomarkers and therapeutic targets for TSCC. |
Pubmed ID | 30755833 |
Year | 2019 |
Title | Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma. |
External Links
Links for AL163952.1 | GenBank HGNC NONCODE |
Links for tongue squamous cell carcinoma | OMIM COSMIC |